Day: November 19, 2020

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (NASDAQ: PNNT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2020.HIGHLIGHTSQuarter ended September 30, 2020($ in millions, except per share amounts)CONFERENCE CALL AT 10:00 A.M. EST ON NOVEMBER 20, 2020PennantPark Investment Corporation (“we,” “our,” “us” or the “Company”) will host a conference call at 10:00 a.m. (Eastern Standard Time) on Friday, November 20, 2020 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing toll-free (866) 548-4713 approximately 5-10 minutes prior to the call. International callers should dial (323) 794-2093. All callers should reference conference ID #2765446 or PennantPark Investment Corporation. An...

ATHENS, Greece, Nov. 19, 2020 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today its results for the three and nine-month period ended September 30, 2020.Third Quarter 2020 Highlights:Total net revenues of $12.3 million. Net income of $0.2 million; net income attributable to common shareholders (after a $0.2 million dividend on Series B Preferred Shares) of $0.03 million or $0.01 earnings per share basic and diluted. Adjusted net loss attributable to common shareholders1 for the period was $1.5 million or $0.261 per share basic and diluted. Adjusted EBITDA1 was $1.2 million.An average of 16.52 vessels were owned and operated during the third quarter of 2020 earning an average...

– Human clinical testing now underway with Codiak’s first two candidates, exoIL-12™ and exoSTING™ –– Initial safety results and preliminary systemic exposure/pharmacokinetics of exoIL-12 in healthy volunteers anticipated YE 2020 –– Biomarker, safety and clinical outcome results in cancer patients anticipated mid-2021 for both exoSTING and exoIL-12 –CAMBRIDGE, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage company focused on pioneering the development of exosome-based therapeutics, today reported third quarter 2020 financial results and operational progress.“Codiak was founded to realize the potential of engineered exosomes as a new and important class of biologic medicines for the treatment of a broad range of diseases,” said Douglas E. Williams, Ph.D., President and Chief...

SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2020.Recent HighlightsRecorded net sales of $11.8 million for the third quarter of 2020, representing a 6% increase over the third quarter of 201931% growth in Core Products over Q3 2019Completed initial public offering, raising approximately $43.0 million in net proceeds, after deducting underwriting fees and other expensesAwarded “breakthrough technology” designation and subsequent group purchasing agreement from Premier Inc. to provide its alliance of approximately 4,100 U.S. hospitals and...

Completed Successful $80 million Public OfferingPresented Encouraging Data for NUC-3373 and NUC-7738 at the ESMO Virtual Congress 2020EDINBURGH, United Kingdom, Nov. 19, 2020 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the third quarter ended September 30, 2020 and provided an update on its broad clinical program with its transformative ProTide therapeutics.As of September 30, 2020, NuCana had cash and cash equivalents of £100.7 million compared to £47.8 million at June 30, 2020 and £52.0 million at December 31, 2019. This cash balance includes the net proceeds from NuCana’s public offering in September 2020. NuCana continues to advance its various clinical programs and reported a net loss of £8.4 million for the quarter ended September 30, 2020, as compared to £3.9 million for the quarter ended September...

Third Quarter Total Revenues of $1.11 Billion, Up 17.9% Year Over YearSubscription Revenue of $968.5 Million, Up 21.3% Year Over YearSubscription Revenue Backlog of $8.87 Billion, Up 23.4% Year Over YearPLEASANTON, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ: WDAY), a leader in enterprise cloud applications for finance and human resources, today announced results for the fiscal 2021 third quarter ended Oct. 31, 2020.Fiscal 2021 Third Quarter ResultsTotal revenues were $1.11 billion, an increase of 17.9% from the third quarter of fiscal 2020. Subscription revenue was $968.5 million, an increase of 21.3% from the same period last year.Operating loss was $14.1 million, or negative 1.3% of revenues, compared to an operating loss of $110.3 million, or negative 11.8% of revenues, in the same period last year. Non-GAAP...

Third Quarter and Recent Highlights:Net revenues of $18.2 million, up 135.3% year-over-yearGross systems shipped of 10,077, up 91.7% year-over-yearReturn accrual rate of 25.2%, a 10.1 percentage point improvement year-over-yearGross margin of 70.1%, up 16.5 percentage points year-over-yearSales and marketing expense as a percent of net revenues of 67.9%, a 52.3 percentage point improvement year-over-yearLoss from operations of ($7.6) million, compared to ($12.0) million in the third quarter of 2019Completed initial public offering of 9,029,629 shares of common stock on October 20, 2020, raising approximately $148 million in net proceedsSAN JOSE, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) — Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today reported its financial...

TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announced financial results for the third quarter ended September 30, 2020. All financial results are stated in US dollars, unless otherwise noted.“Rallying off our strong performance in the second quarter, the third quarter reflects the results of continued revenue growth and cost reductions, exceptional vendor management and operational excellence,” stated Jeff Yapp, Chief Executive Officer of GLH. “In addition to this being our first cashflow-positive quarter, we have surpassed the total revenue generated in all of fiscal 2019 in just three quarters.”The increase was led by...